Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected- Iran begins cloud seeding to induce rain amid historic drought
- Anger as German family business group opens talks with far-right AfD
- 'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- Find the Historical backdrop of the Modern Unrest: Changing Society and Innovation
- Why do people get headaches and migraines? A child neurologist explains the science of head pain and how to treat it
- Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
- A Republican elected governor in California? It's not as far-fetched as it sounds.
